Royalty Pharma plcRPRXNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank100
Year-over-Year Change
Year-over-year research & development expense growth
Latest
22500.00%
↑ 874% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthAccelerating
Average
2309.07%
Historical baseline
| Period | Value |
|---|---|
| 2025 | 22500.00% |
| 2024 | -96.15% |
| 2023 | -70.64% |
| 2022 | -11.48% |
| 2021 | 661.09% |
| 2020 | -68.34% |
| 2019 | -78.85% |
| 2018 | 233.10% |
| 2017 | 29.49% |
| 2016 | -7.48% |